A dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours

This dose escalation study was designed to determine the recommended dose of the multi-targeted cell cycle inhibitor indisulam in combination with capecitabine in patients with solid tumours and to evaluate the pharmacokinetics of the combination. Thirty-five patients were treated with indisulam on...

Descripción completa

Detalles Bibliográficos
Autores principales: Siegel-Lakhai, W S, Zandvliet, A S, Huitema, A D R, Tibben, M M, Milano, G, Girre, V, Diéras, V, King, A, Richmond, E, Wanders, J, Beijnen, J H, Schellens, J H M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361705/
https://www.ncbi.nlm.nih.gov/pubmed/18414469
http://dx.doi.org/10.1038/sj.bjc.6604300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361705/
https://www.ncbi.nlm.nih.gov/pubmed/18414469
http://dx.doi.org/10.1038/sj.bjc.6604300

Ejemplares similares